Company · Ownership research

Climb Bio, Inc. CLYM

CIK 0001768446

Form 4 transactions dated Nov 1, 2023 to Nov 11, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through Sep 30, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $50.73M
Sold: $6.15M

Nov 1, 2023 – Sep 30, 2026
Available records · partial months are marked ·

Insiders in this window

202410 of 16 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 19, 2024	Pimblett Emily CHIEF ACCOUNTING OFFICER	Sale10b5-1 footnote	$2.49K 1,235 shares sold	9.83% sold Direct holding	▾
Sep 20, 2024	Pimblett Emily CHIEF ACCOUNTING OFFICER	Sale10b5-1 footnote	$9.74K 1,191 shares sold	13.60% sold Direct holding	▾
Jul 22, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$554.17K 69,005 shares sold	68.78% sold Direct holding	▾
Jul 19, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$434.33K 60,201 shares sold	37.50% sold Direct holding	▾
Jul 18, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$267.33K 38,576 shares sold	19.38% sold Direct holding	▾
Jul 17, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$22.16K 3,207 shares sold	1.59% sold Direct holding	▾
Jul 16, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$356.50K 50,000 shares sold	19.82% sold Direct holding	▾
Jul 15, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$297.06K 42,377 shares sold	14.38% sold Direct holding	▾
Jul 12, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$353.50K 50,000 shares sold	14.51% sold Direct holding	▾
Jul 11, 2024	Morisset Valerie EVP, R&D AND CSO	Sale	$355.50K 50,000 shares sold	12.67% sold Direct holding	▾

Showing 16 / 16 record groups in 2024. The complete set is available through the API.

Climb Bio, Inc. · CLYM

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 16 of 16 purchase / sale groups and 26 of 26 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"CLYM","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.